RU2003134829A - METHOD FOR PREDICTING PRESSURE CANCER RECIDIVITY AFTER RADICAL PROSTATECTOMY - Google Patents

METHOD FOR PREDICTING PRESSURE CANCER RECIDIVITY AFTER RADICAL PROSTATECTOMY Download PDF

Info

Publication number
RU2003134829A
RU2003134829A RU2003134829/14A RU2003134829A RU2003134829A RU 2003134829 A RU2003134829 A RU 2003134829A RU 2003134829/14 A RU2003134829/14 A RU 2003134829/14A RU 2003134829 A RU2003134829 A RU 2003134829A RU 2003134829 A RU2003134829 A RU 2003134829A
Authority
RU
Russia
Prior art keywords
cancer
recidivity
radical prostatectomy
predicting pressure
predicting
Prior art date
Application number
RU2003134829/14A
Other languages
Russian (ru)
Other versions
RU2254812C1 (en
Inventor
Евсей Борисович Мазо (RU)
Евсей Борисович Мазо
Максим Эдуардович Григорьев (RU)
Максим Эдуардович Григорьев
Денис Васильевич Лебедев (RU)
Денис Васильевич Лебедев
Елена Владимировна Соловьева (RU)
Елена Владимировна Соловьева
Original Assignee
Российский государственный медицинский университет (RU)
Российский государственный медицинский университет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Российский государственный медицинский университет (RU), Российский государственный медицинский университет filed Critical Российский государственный медицинский университет (RU)
Priority to RU2003134829/14A priority Critical patent/RU2254812C1/en
Publication of RU2003134829A publication Critical patent/RU2003134829A/en
Application granted granted Critical
Publication of RU2254812C1 publication Critical patent/RU2254812C1/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Claims (1)

Способ диагностики рецидива рака предстательной железы после радикальной простатэктомии, отличающийся тем, что исследуют мочу больного на уровень концентрации простатического специфического антигена и при его увеличении в период до и после массажа ложа предстательной железы прогнозируют рецидив заболевания.A method for diagnosing recurrence of prostate cancer after radical prostatectomy, characterized in that the patient's urine is examined for a concentration level of a specific prostatic antigen, and with its increase in the period before and after massage of the prostate bed, relapse is predicted.
RU2003134829/14A 2003-12-02 2003-12-02 Method for predicting the relapse of prostatic cancer after radical prostatectomy RU2254812C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2003134829/14A RU2254812C1 (en) 2003-12-02 2003-12-02 Method for predicting the relapse of prostatic cancer after radical prostatectomy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003134829/14A RU2254812C1 (en) 2003-12-02 2003-12-02 Method for predicting the relapse of prostatic cancer after radical prostatectomy

Publications (2)

Publication Number Publication Date
RU2003134829A true RU2003134829A (en) 2005-05-10
RU2254812C1 RU2254812C1 (en) 2005-06-27

Family

ID=35746602

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003134829/14A RU2254812C1 (en) 2003-12-02 2003-12-02 Method for predicting the relapse of prostatic cancer after radical prostatectomy

Country Status (1)

Country Link
RU (1) RU2254812C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2611380C2 (en) * 2015-06-23 2017-02-21 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации (ФГБУ "НМИРЦ" Минздрава России) Method of pre-operative prediction of stage and aggressiveness of prostate cancer

Also Published As

Publication number Publication date
RU2254812C1 (en) 2005-06-27

Similar Documents

Publication Publication Date Title
DE60220719D1 (en) ANTIBODIES TO THE MUC18 ANTIGEN
NO20023402D0 (en) Mixtures and Methods for the Treatment and Diagnosis of Prostate Cancer
BRPI0410842A (en) prostate stem cell antigens (psca) variants and sub-sequences thereof
ATE423191T1 (en) PROSTATE STEM CELL ANTIGEN (PSCA) AND ITS USES
NO20020554L (en) Antibody molecules with specificity for human tumor necrosis factor alpha, and use thereof
NO20034020D0 (en) New MHC Molecular Compounds, and Methods for Using These Compounds for Diagnosis and Therapy, and the Use of MHC Molecules
EP2444505A3 (en) Urine markers for detection of bladder cancer
ATE478952T1 (en) 36P6D5: SECRETED TUMOR PROTEIN
IS6195A (en) Use of antibodies against CD20 for the treatment of silencing
CY1116052T1 (en) THERAPEUTIC AND DIAGNOSTIC ANTI-HSR70 ANTIBODIES
WO2003053223A3 (en) Prostate cancer diagnosis and outcome prediction by expression analysis
NO20032395D0 (en) Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
IS6965A (en) Ganglioside-associated recombinant antibodies and their use in the diagnosis and treatment of tumors
DE69618447T2 (en) EARLY DETECTION OF PROSTATE CANCER (CAP) BY DETERMINING THE CONCENTRATION RATIO BETWEEN PROSTATE-SPECIFIC ANTIGEN (PSA) AND HUMAN Glandular Calliocreine (HGK-1)
DE60045075D1 (en) ANTI-EPHA2 ANTIBODY AS CANCER DIAGNOSTIC
EP1410022A4 (en) Detection and treatment of prostate cancer
RU2003134829A (en) METHOD FOR PREDICTING PRESSURE CANCER RECIDIVITY AFTER RADICAL PROSTATECTOMY
DE60014064D1 (en) EINETENASCIN-C ISOFORM AS A MARKER FOR NEOPLASMS
ATE409002T1 (en) DEVICE FOR PROSTATE CANCER DIAGNOSIS
ATE429440T1 (en) FORMS OF PROSTATE-SPECIFIC ANTIGENS AND METHOD FOR THE DETECTION THEREOF
FR2859910B1 (en) USE OF 1-ALPHA-FLUORO-25-HYDROXY-16,23E-DIENE-26,27-BISHOMO-20-EPI-CHOLECALCIFEROL FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
WO2002025286A3 (en) Methods for the diagnosis of neoplastic disorders using angiogenin
RU2003117816A (en) METHOD FOR PREDICTING DEVELOPMENT OF METACHRON BREAST CANCER
WO2002044419A3 (en) Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
Borkowski Superficial bladder cancer T1G3: the choice of treatment.

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20071203